PCRX

PCRX Long-Term Debt

$401.82MQuarterly · USD

Period ending:

PCRX FY Long-Term DebtUSD
PCRX FY Long-Term Debt2008-12-31: $0.002009-12-31: $0.002010-12-31: $21.87M2011-12-31: $20.07M2012-12-31: $26.05M2013-12-31: $0.002014-12-31: $0.002015-12-31: $0.002016-12-31: $108.74M2017-12-31: $276.17M2018-12-31: $290.59M2019-12-31: $346.98M2020-12-31: $384.06M2021-12-31: $746.26M2022-12-31: $720.63M2023-12-31: $568.60M2024-12-31: $428.19M2025-12-31: $444.54M$746.26M$0.00
2008-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

PCRX long-term debt history

Debt obligations due beyond one year. The available annual fiscal periods series contains 18 observations from Dec 31, 2008 to Dec 31, 2025.

Pacira Biosciences Inc Long-Term Debt — Annual fiscal periods (USD)
Period endingLong-Term Debt (USD)
444,541,000
428,190,000
568,602,000
720,625,000
746,257,000
384,055,000
346,983,000
290,592,000
276,173,000
108,738,000
0
0
0
26,048,000
20,074,000
21,869,000
0
0

Compare long-term debt

All PCRX financial metrics · PCRX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.